Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 10

Clinical and surgical approach to parathyroid adenomas: A single-center experience

Pages
2259–2265
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mean follow-upwas 57.2+39.5 months.Conclusion: Proper preoperative evaluation, careful exploration, frozen examination and rapid parathormone test increase thesuccess of parathyroid adenoma surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Primary hyperparathyroidism is a clinical condition caused by excessive parathyroid secretion of the parathyroid glands andrelated hypercalsemia.
📊
Key Findings & Data:In this study, we aimed to present the results ofpatients operated on due to parathyroidadenoma in our clinic.Material and Methods: IPatients who underwent surgery for parathyroid adenoma in our clinic between January 2007 and January2019 were included in the study.
💡
Conclusion & Impact:The mean follow-upwas 57.2+39.5 months.Conclusion: Proper preoperative evaluation, careful exploration, frozen examination and rapid parathormone test increase thesuccess of parathyroid adenoma surgery.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Primary hyperparathyroidism is a clinical condition caused by excessive parathyroid secretion of the parathyroid glands andrelated hypercalsemia. Hyperparathyroidism is a common cause of hypercalcemia. In this study, we aimed to present the results ofpatients operated on due to parathyroidadenoma in our clinic.Material and Methods: IPatients who underwent surgery for parathyroid adenoma in our clinic between January 2007 and January2019 were included in the study. Clinical characteristics, biochemical data, treatment methods and results of the patients wereanalyzed retrospectively.Results: 156 patients with a mean age of 50.8 years participated in the study. Female sex was 76.2%. Preoperative calcium levelwas found as 11.2+1.02 mg/dl, Parathormone level was found as 114.7+109.5 pg / ml. The most common clinical presentationwas asymptomatic hypercalcemia (48.7%). While 89.7% of the patients had only parathoridectomy, 3.2% had total thyroidectomyand 7.1% had lobectomy due to associated thyroid pathology (10.3%). Intraoperative rapid parathormone was used in 54.4% ofthe patients. Frozen examination was performed in all patients. The most common localization was inferior left 39.7%. The mostcommon ectopic localization was intratymic at 2.6%. The mean duration of postoperative hospital stay was 3.81+2.69 days. Threepatients (1.9%) had persistent hyperparathyroidism and 6 patients (3.8%) had recurrent hyperparathyroidism. The mean follow-upwas 57.2+39.5 months.Conclusion: Proper preoperative evaluation, careful exploration, frozen examination and rapid parathormone test increase thesuccess of parathyroid adenoma surgery.

🔖

Cite This Article

SAKMAN, G., DALCI, K., TOPAL, U., SARITAŞ, A. G., GÜNAY, I. B., UĞUZ, A. H., ÜNAL, A. G. (2022). Clinical and surgical approach to parathyroid adenomas: A single-center experience. Annals of Medical Research, Cilt: 26 - Sayı: 10, 2259–2265. https://ajindex.com/articles/447019

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Uludag M, Aygun N. Primary Hyperparathyroidism: Current Situation in the Clinical and Biochemical Presentation. MedBull Sisli Etfal Hosp 2016;50:171– 80
  2. Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 2013;98:1122-9
  3. Pappachan JM, Elnaggar MN, Sodi R, et al. Primary hyperparathyroidism: findings from the retrospective evaluation of casesover a 6-year period from a regional UK centre. Endocrine 2018;62:174-81
  4. Felger EA, Kandil E. Primary hyperparathyroidism. Otolaryngol Clin North Am 2010;43:417-32
  5. Reid L, Muthukrishnan B, Patel D, et al Presentation, diagnostic assessment and surgical outcomes in primary hyperparathyroidism: a single centers experience. Endocrine Connections 2018;7:1105–15
  6. Wilhelm SM, Wang TS, Ruan D, et al. The american association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 2016;151:959–68
  7. Sethi N, England RJA. Parathyroid surgery: from inception to the modern day. Br J Hosp Med (Lond) 2017;78:333-7
  8. Tolley N, Garas G, Palazzo F, et al, Darzi A, Arora A Long-term prospective evaluation comparing robotic parathyroidectomy with minimally invasive open parathyroidectomy for primary hyperparathyroidism. Head Neck 2016;38:300–6
  9. Bilezikian JP, Khan AA, Potts JT Jr, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J ClinEndocrinol Metab 2009; 94: 335–39
  10. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metabolism 2014;99:3561-69
  11. Khan AA, Hanley DA, Rizzoli R, et al.Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 2017;28:1–19
  12. Irvin GL, Dembrow VD, Prudhomme DL. Operative monitoring of parathyroid gland hyperfunction. Am J Surg 1991;162:299-302
  13. Khan A, Bilezikian J. Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 2000;163:84–7
  14. Bilezikian JP, Cusano NE, Khan AA, e t al. Primary hyperparathyroidism. Nat Rev Dis Prim 2016;2:16033
  15. Percivale A, Gnerre P, Damonte G, et al. Management primary hyperparathyroidism: Epidemiology, clinical features, diagnostic tools and current. Italian J Me